QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 9 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q4 2012. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2014 | $3,086,000 | -42.7% | 47,527 | -52.0% | 0.22% | -43.5% |
Q4 2013 | $5,386,000 | +2.5% | 98,917 | +9.2% | 0.39% | -2.2% |
Q3 2013 | $5,256,000 | +65.6% | 90,617 | +29.7% | 0.40% | +63.9% |
Q2 2013 | $3,174,000 | +39575.0% | 69,857 | +28182.2% | 0.24% | -89.6% |
Q1 2013 | $8,000 | +14.3% | 247 | 0.0% | 2.35% | -4.9% |
Q4 2012 | $7,000 | – | 247 | – | 2.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 2,251,660 | $146,200,000 | 28.53% |
Palo Alto Investors LP | 1,938,990 | $125,898,000 | 5.20% |
Valiant Capital Management, L.P. | 599,100 | $38,900,000 | 4.77% |
Espalier Global Management LLC | 1,284,800 | $83,422,000 | 4.66% |
CAPITAL MANAGEMENT CORP /VA | 178,365 | $11,581,000 | 3.95% |
Freestone Capital Holdings, LLC | 303,127 | $19,682,000 | 3.49% |
RIVULET CAPITAL, LLC | 58,000 | $3,766,000 | 3.41% |
Formidable Asset Management, LLC | 52,640 | $4,161,000 | 2.91% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,039,865 | $67,518,000 | 2.76% |
GROESBECK INVESTMENT MANAGEMENT CORP /NJ/ | 89,561 | $5,815,000 | 2.62% |